Loading...
Phathom Pharmaceuticals, Inc.
PHAT•NASDAQ
HealthcareBiotechnology
$8.92
$4.23(90.19%)
Phathom Pharmaceuticals, Inc. (PHAT) Quarterly Earnings Reports & Financial Results
Analyze Phathom Pharmaceuticals, Inc.’s revenue, EPS, and earnings surprises to assess performance and investor sentiment over recent quarters.
Total Reports
0
Avg EPS
N/A
Avg Revenue
N/A
Beats Estimates
0 out of 0
Max EPS
N/A
Min EPS
N/A
Earnings Visualization
Visual comparison of Phathom Pharmaceuticals, Inc.’s actual vs. estimated earnings across recent quarters.
No data available
Phathom Pharmaceuticals, Inc. (PHAT) Quarterly Earnings Details
Detailed breakdown of Phathom Pharmaceuticals, Inc.’s earnings per share (EPS), revenue estimates vs. actuals, and earnings surprises by quarter.